GUIDELINE
Japanese Clinical Practice Guideline for Diabetes 2019
E. Araki, A. Goto, T. Kondo, M. Noda, H. Noto, H. Origasa, H. Osawa, A. Taguchi, Y. Tanizawa, K. Tobe, N. Yoshioka 165-223
CONSENSUS REPORT
Medical nutrition therapy and dietary counseling for patients with diabetes -energy, carbohydrates, protein intake and dietary counseling
T. Yamauchi, H. Kamiya, K. Utsunomiya, H. Watada, D. Kawanami, J. Sato, M. Kitada, D. Koya, N. Harada, K. Shide, E. Joo, R. Suzuki, R. Bouchi, Y. Ohta, T. Kondo 224-239
COMMENTARY
INTRODUCTION TO MINI-REVIEWS
MINI-REVIEWS
ORIGINAL ARTICLES
Work-related, personal, and diabetes-related factors relevant to dropout from outpatient diabetes treatment visits among Japanese male employees with diabetes
N. Sonoda, S. Watanabe, Y. Ohno, K. Godai, C. Hatamochi, Y. Sugimoto, S. Okawa, M. Shikama, A. Morimoto 261-268
Efficacy and safety of a combination of an insulin secretagogue and a dipeptidyl peptidase-4 inhibitor in Japanese patients with type 2 diabetes mellitus; the repaglinide glucose oscillation study in Fukuoka (REGO-F)
Y. Terawaki, C. Iwaya, T. Nomiyama, D. Shimono, T. Horikawa, Y. Fujimura-Tanaka, T. Shigeoka, N. Hamanoue, R. Motonaga, M. Tanabe, T. Yanase, D. Kawanami, Collaborators in the Repaglinide Glucose Oscillation Study in Fukuoka (REGO-F) trial 274-282
SHORT COMMUNICATION